OICHARTS
8 AMThe 8 AM report →

3BBLACKBIO

3B Blackbio Dx Limited · NSE · INE994E01018 · 115 sessions on record
₹1,646.80▼ −63.60 · −3.7%from ₹1,710.40 the session before · 1 Oct 2026 close · NSE end of day
Open
₹1,690.20
High
₹1,734.00
Low
₹1,617.90
Day's range
₹1206.8% of the previous close
VWAP
₹1,677.54close −1.8% from it
Volume, shares
28,0001.26× the 20-session average
Turnover, ₹ crore
4.7
Trades
3,4008.2 shares per trade
Previous close
₹1,710.40−63.60 to the close
Price band, next session
₹1,482.10 – ₹1,811.5010% either side of the close · dynamic, widened in 5% steps when hit
Day range25% of the way up
₹1,617.90₹1,734.00
52-week range86% of the way up
₹1,085.00 2 Jun₹1,740.00 30 Sept

−5.4% from the high · +52% from the low

Futures and options

No derivatives listed on 3BBLACKBIO

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up115 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close
115 sessions on file · from 20 Apr
3BBLACKBIO close and futures open interest over the last 115 sessions, with Nifty 50 rebased to the first close110315421981axis spans 80%Nifty 503BBLACKBIO20 Apr13 Jul1 Oct115 sessions from 20 Apr to 1 Oct; the price axis spans 80 percent.

Quarterly results

NSE filings

No results filed on record for 3BBLACKBIO yet.

Fundamentals

close ₹1,646.80 on 1 Oct

No results filed on record for 3BBLACKBIO yet, so only the exchange's market figures are shown.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing
Market cap
₹1,400 cron 1 Oct
Price to earnings
—fewer than four consecutive quarters filed
Trailing EPS
—fewer than four consecutive quarters filed
Price to book
—no balance sheet filed yet
Book value a share
—no equity line in the filing
Debt to equity
—no equity line in the filing
Return on equity
—needs two filed balance sheets
Dividend yield
0.91%₹15.00 a share in 365 days
Face value
₹10a share
Shares outstanding
1 cron 1 Oct
PeersBSE sub-group Healthcare Service Provider · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap
Stocks in the BSE sub-group Healthcare Service Provider with market cap, price to earnings and price to book
StockMarket cap ₹P/EP/BClose ₹
LALPATHLABDr. Lal Path Labs Ltd.34,000 cron 1 Oct—13₹2,005.10
VIJAYAVijaya Diagnostic Centre Limited15,000 cron 1 Oct—15₹1,428.00
METROPOLISMetropolis Healthcare Limited11,000 cron 1 Oct—7.3₹537.90
THYROCAREThyrocare Technologies Limited8,500 cron 1 Oct—14₹533.60
NEPHROPLUSNephrocare Health Services Limited6,500 cron 1 Oct—5.8₹648.95
SURAKSHASuraksha Diagnostic Limited1,800 cron 1 Oct—7.5₹350.15
KRSNAAKrsnaa Diagnostics Limited1,800 cron 1 Oct—1.8₹554.85
3BBLACKBIO3B Blackbio Dx Limited1,400 cron 1 Oct——₹1,646.80
ONEGLOBALOne Global Service Provider Limited1,000 cron 1 Oct——₹525.40
HEALTHXHealth X Platform Limited870 cron 1 Oct—1.1₹273.00
GAUDIUMIVFGaudium IVF and Women Health Limited800 cron 1 Oct—5.2₹109.50

Shareholding

NSE filings

No shareholding pattern on record for 3BBLACKBIO yet.

Corporate actions

NSE and BSE records

Nothing upcoming on record; the last was a dividend of ₹5.00 a share, ex-date 22 Sept 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios
Corporate actions of 3BBLACKBIO, upcoming first, then the most recent
Ex-dateActionAmount or ratioRecord dateSource
recent
22 Sept 2026dividend₹5.0022 Sept 2026PR
19 Sept 2025dividend₹4.0019 Sept 2025BSE
17 Sept 2024dividend₹3.00—BSE
Calendaras notified to the exchange
Next results
—no board meeting notified yet
Dividends in 365 days
₹15.00a share · ex-dates inside the year
Last dividend
₹5.00ex-date 22 Sept 2026

Price history

115 sessions on record · to 1 Oct · NSE end of day

3BBLACKBIO is +11.4% over 20 sessions against Nifty's −6.2%, 5.4% below its 52-week high, realised volatility 63% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions
Returns of the stock and Nifty 50 over six windows, longest first
WindowFrom ₹3BBLACKBIO %Nifty 50 %Difference pp
60 sessionssince 8 Jul₹1,166.21▲ +41%▼ −6.1%+47
20 sessionssince 2 Sept₹1,478.54▲ +11%▼ −6.2%+18
5 sessionssince 24 Sept₹1,405.96▲ +17%▼ −2.8%+20
1 sessionsince 30 Sept₹1,710.43▼ −3.7%▼ −0.88%−2.8
Averages of the closeclose against each average
5-session average
₹1,604.18close +2.7% from it
20-session average
₹1,457.81close +13% from it
50-session average
₹1,342.86close +23% from it
Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average
Average true range, 14
₹835.1% of the close
Average day's range, 20
₹905.5% of the close
Volume against 20 sessions
1.26×28,000 vs 21,000 average
Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell
Realised volatility, 20
63%≈ ±4.0% a session · moved more than that on 8 of 20
Realised volatility, 60
51%≈ ±3.2% a session · moved more than that on 20 of 60
Beta to Nifty, 60
0.15moved with Nifty on 31 of 60 sessions
Up and down sessionscloses above and below the previous close
Last 20 sessions
10 up · 10 downof 20
Last 60 sessions
33 up · 26 downof 59
Best session, 250
▲ +8.8%28 Sept
Worst session, 250
▼ −11%1 Jun

0 bulletins on 3BBLACKBIO

The desk has not written about 3B Blackbio Dx Limited yet. The tape carries every bulletin as it is published.

About 3B Blackbio Dx Limited

exchange masters as of 18 Sept 2026 · classification by BSE
Company
3B Blackbio Dx Limited
Exchange
NSE · BSE 532067, group B
Listed on NSE
20 Apr 2026
Classification
Healthcare › Healthcare Services › Healthcare Service Provider
Index
BSE Healthcare
Face value
₹10 a share
ISIN
INE994E01018
Sessions on record
115
Price source
NSE UDiFF bhavcopy · end of day · delayed
Filings
NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed
2 Oct, 12:43 am IST
Bulletins
0 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.